BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30365456)

  • 21. Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature.
    Kleppe M; Bruls J; Van Gorp T; Massuger L; Slangen BF; Van de Vijver KK; Kruse AJ; Kruitwagen RF
    Gynecol Oncol; 2014 May; 133(2):155-8. PubMed ID: 24552756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with misdiagnosis of frozen section of mucinous borderline ovarian tumor.
    Zhang W; Jia S; Xiang Y; Yang J; Jia C; Leng J
    J Int Med Res; 2019 Jan; 47(1):96-104. PubMed ID: 30198356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.
    Uzan C; Nikpayam M; Ribassin-Majed L; Gouy S; Bendifallah S; Cortez A; Rey A; Duvillard P; Darai E; Morice P
    Ann Oncol; 2014 Jul; 25(7):1312-1319. PubMed ID: 24713312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology Group study.
    Guvenal T; Dursun P; Hasdemir PS; Hanhan M; Guven S; Yetimalar H; Goksedef BP; Sakarya DK; Doruk A; Terek MC; Saatli B; Guzin K; Corakci A; Deger E; Celik H; Cetin A; Ozsaran A; Ozbakkaloglu A; Kolusari A; Celik C; Keles R; Sagir FG; Dilek S; Uslu T; Dikmen Y; Altundag O; Ayhan A
    Gynecol Oncol; 2013 Dec; 131(3):546-50. PubMed ID: 24016409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathologic analysis of ovarian serous and mucinous borderline tumors].
    Zhong C; Yu X; Zhang J; Wei B; Luo B; Sun L; Zhang N; Fu Q
    Zhonghua Bing Li Xue Za Zhi; 2001 Aug; 30(4):253-5. PubMed ID: 11758211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective study of characteristics and hyperthermia intraperitoneal perfusion in mucinous borderline ovarian tumor and mucinous ovarian carcinoma.
    He X; Ying R; Jia L; Li Y; Li R
    Gland Surg; 2023 Apr; 12(4):453-464. PubMed ID: 37200926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma.
    Kajiyama H; Suzuki S; Utsumi F; Yoshikawa N; Nishino K; Ikeda Y; Niimi K; Yamamoto E; Kawai M; Shibata K; Nagasaka T; Kikkawa F
    Int J Clin Oncol; 2019 Aug; 24(8):950-956. PubMed ID: 30941534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
    Ren J; Peng Z; Yang K
    Gynecol Oncol; 2008 Aug; 110(2):162-7. PubMed ID: 18495223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors.
    Moro F; Zannoni GF; Arciuolo D; Pasciuto T; Amoroso S; Mascilini F; Mainenti S; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):261-270. PubMed ID: 28782867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.
    Avril S; Hahn E; Specht K; Hauptmann S; Höss C; Kiechle M; Höfler H; Schmalfeldt B
    Gynecol Oncol; 2012 Dec; 127(3):516-24. PubMed ID: 23000388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary ovarian mucinous adenocarcinoma of intestinal type: a clinicopathologic study of 46 cases.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Siriaunkgul S
    Int J Gynecol Pathol; 2014 Mar; 33(2):176-85. PubMed ID: 24487473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
    Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
    Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent intestinal mucinous borderline tumors of the ovary: a report of 5 cases causing problems in diagnosis, including distinction from mucinous carcinoma.
    Irving JA; Clement PB
    Int J Gynecol Pathol; 2014 Mar; 33(2):156-65. PubMed ID: 24487471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases.
    de Nictolis M; Montironi R; Tommasoni S; Valli M; Pisani E; Fabris G; Prat J
    Int J Gynecol Pathol; 1994 Jan; 13(1):10-21. PubMed ID: 8112952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
    Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
    Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.